POTELIGEO

Medicinal product

(Invented) name

POTELIGEO

Active substance (s)

Mogamulizumabas

Strength

4 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FX09, mogamulizumab

Marketing authorisation holder

Kyowa Kirin Holdings B.V., Nyderlandai

Date of authorisation

2018-11-22

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Concentrate for solution for infusion	1 ml
Mogamulizumabas	4 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
100640	86750	1086750	flakonas	5 ml N1		Receptinis	EU/1/18/1335/001	Netiekiama	2025-09-25	-	Yes	2025-10-10	2026-07-01

Stadijos

Data	Stadija
2018-11-22	Registruotas